Loading…
Reported covered position: Chief of Staff, Rep. Stacey Plaskett; Legislative Director, Rep. G.K. Butterfield; Associate Director, Democratic Steering and Outreach Committee, Sen. Harry Reid; Legislative Director, Rep. Chaka Fattah; Staff Assistant, Rep. Chaka Fattah
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
American Rescue Plan Act of 2021
Client: ABBVIE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to patient access, Issues related to pharmaceutical manufacturing, Issues related to treatment of endometriosis, Patent reform H.R.1319 - American Rescue Plan Act of 2021
American Rescue Plan Act of 2021
Client: ABBVIE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to patient access, Issues related to pharmaceutical manufacturing, Issues related to treatment of endometriosis, Patent reform H.R.1319 - American Rescue Plan Act of 2021
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
MCDONALD'S CORPORATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2021 · third_quarter · Q3
Issues related to workforce access to education
Filing targets: HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), SENATE
MCDONALD'S CORPORATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2021 · second_quarter · Q2
Source: Senate LDA
| CENTENE CORPORATION |
| 9 |
| 2019–2020 |
| AMGEN USA, INC. | 8 | 2019–2020 |
| NATIONAL COLLEGIATE ATHLETIC ASSOCIATION | 8 | 2019–2020 |
| SPARK THERAPEUTICS, INC. | 8 | 2019–2020 |
| AMERICAN PETROLEUM INSTITUTE | 7 | 2019–2020 |
| BAXTER HEALTHCARE CORPORATION | 7 | 2019–2020 |
| DEL MONTE FRESH PRODUCE COMPANY | 7 | 2019–2020 |
| FEDEX CORPORATION | 7 | 2019–2020 |
| Red Rock Resorts, Inc. | 7 | 2019–2020 |
| CONSTELLATION ENERGY GENERATION, LLC | 6 | 2019–2020 |
| HEB GROCERY COMPANY, LP | 6 | 2019–2020 |
| NATIONAL HEAD START ASSOCIATION | 6 | 2019–2020 |
| PWC US GROUP LLP | 6 | 2019–2020 |
| ROYAL CARIBBEAN CRUISES LTD | 6 | 2020 |
| PLASTICS INDUSTRY ASSOCIATION | 5 | 2020 |
| AMP ROBOTICS | 4 | 2020 |
| BECKMAN COULTER DIAGNOSTICS | 4 | 2020 |
| CADENCE EDUCATION | 4 | 2020 |
| CENGAGE | 4 | 2020 |
| CARS.COM | 3 | 2020 |
| COINSTAR | 3 | 2020 |
| FRIENDS OF THE NATIONAL MUSEUM OF AMERICAN JEWISH HISTORY, LLC | 3 | 2020 |
| ICONSTITUENT | 3 | 2020–2021 |
| PATHEMAGX | 3 | 2020 |
| THE EARLY CARE AND EDUCATION CONSORTIUM | 3 | 2020 |
| HARMONY BIOSCIENCES | 2 | 2019 |
| AMERICAN SHORT LINE AND REGIONAL RAILROAD ASSOCIATION | 1 | 2019 |
| CITY AND COUNTY OF DENVER | 1 | 2020 |
| CREDIT KARMA AN INTUIT AFFILIATE | 1 | 2019 |
| GOGO, INC. | 1 | 2020 |
| NATIONAL CABLE TELECOMMUNICATIONS ASSOCIATION | 1 | 2020 |
| NATIONAL LEAGUE OF CITIES | 1 | 2020 |
| PARK HOTELS & RESORTS INC. | 1 | 2020 |
Arctic Cultural and Coastal Plain Protection Act
Client: AMERICAN PETROLEUM INSTITUTE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to USMCA, workforce development, and infrastructure; issues relates to offshore exploration; HR 205, HR 1941, HR 1146
Arctic Cultural and Coastal Plain Protection Act
Client: AMERICAN PETROLEUM INSTITUTE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to USMCA, workforce development, and infrastructure; issues relates to offshore exploration; HR 205, HR 1941, HR 1146
Arctic Cultural and Coastal Plain Protection Act
Client: AMERICAN PETROLEUM INSTITUTE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to workforce development and infrastructure; issues relates to offshore exploration; HR 205, HR 1941, HR 1146
Consolidated Appropriations Act, 2021
Client: HEB GROCERY COMPANY, LP · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to the Supplemental Nutrition Assistance Program S.2220 Open and Responsive Government Act of 2019 - issues related to exemptions to the Freedom of Information Act Issues related meat inspection procedures H.R.133 Consolidated Appropriations Act, 2021 - Issues related to COVID-19
Consolidated Appropriations Act, 2021
Client: THE EARLY CARE AND EDUCATION CONSORTIUM · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to early childhood education; Child Care and Development Block Grant (CCDBG); Child and Adult Care Food Program (CACFP) S.749/H.R.1696 - PACE Act H.R. 748 CARES Act, H.R.133 Consolidated Appropriations Act, 2021 - Issues related to COVID-19 relief
Consolidated Appropriations Act, 2021
Client: BECKMAN COULTER DIAGNOSTICS · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to COVID-19; H.R. 133 Consolidated Appropriations Act, 2021
Consolidated Appropriations Act, 2021
Client: CENTENE CORPORATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
ACA stabilization; Medicare Advantage; Medicaid H.R.133 - Consolidated Appropriations Act, 2021 - Issues related to COVID-19 relief Tricare telehealth issues Independence at home
Consolidated Appropriations Act, 2021
Client: ABBVIE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to patient access Issues related to pharmaceutical manufacturing Issues related to treatment of endometriosis Patent reform - S. 1416 - Affordable Prescriptions for Patients Act of 2019 Medicare Part D H.R. 748 CARES Act - Issues related to COVID-19 relief S. 4397/H.R.6383 - Uterine Fibroid Research and Education Act of 2020 H.R.133 - Consolidated Appropriations Act, 2021
Consolidated Appropriations Act, 2021
Client: CENTENE CORPORATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
ACA stabilization; Medicare Advantage; Medicaid H.R.133 - Consolidated Appropriations Act, 2021 - Issues related to COVID-19 relief Tricare telehealth issues Independence at home
Consolidated Appropriations Act, 2021
Client: ABBVIE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to patient access Issues related to pharmaceutical manufacturing Issues related to treatment of endometriosis Patent reform - S. 1416 - Affordable Prescriptions for Patients Act of 2019 Medicare Part D H.R. 748 CARES Act - Issues related to COVID-19 relief S. 4397/H.R.6383 - Uterine Fibroid Research and Education Act of 2020 H.R.133 - Consolidated Appropriations Act, 2021
PACE Act
Client: THE EARLY CARE AND EDUCATION CONSORTIUM · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to early childhood education; Child Care and Development Block Grant (CCDBG); Child and Adult Care Food Program (CACFP) S.749/H.R.1696 - PACE Act H.R. 748 CARES Act, Issues related to COVID-19 relief
PACE Act
Client: THE EARLY CARE AND EDUCATION CONSORTIUM · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to early childhood education; Child Care and Development Block Grant (CCDBG); Child and Adult Care Food Program (CACFP) S.749/H.R.1696 - PACE Act H.R. 748 CARES Act, H.R.133 Consolidated Appropriations Act, 2021 - Issues related to COVID-19 relief
PACE Act
Client: THE EARLY CARE AND EDUCATION CONSORTIUM · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to early childhood education; Child Care and Development Block Grant (CCDBG); Child and Adult Care Food Program (CACFP) S.749/H.R.1696 - PACE Act H.R. 748 CARES Act, Issues related to COVID-19 relief
Student-Athlete Equity Act
Client: NATIONAL COLLEGIATE ATHLETIC ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to athletic scholarships, health and safety, academic success, the collegiate athletic model, amateurism, and higher education H.R. 1804 - Student Athlete Equity Act
Student-Athlete Equity Act
Client: NATIONAL COLLEGIATE ATHLETIC ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to athletic scholarships, health and safety, academic success, the collegiate athletic model, amateurism, and higher education H.R. 1804 - Student Athlete Equity Act
Student-Athlete Equity Act
Client: NATIONAL COLLEGIATE ATHLETIC ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to athletic scholarships, health and safety, academic success, the collegiate athletic model, amateurism, and higher education H.R. 1804 - Student Athlete Equity Act
Student-Athlete Equity Act
Client: NATIONAL COLLEGIATE ATHLETIC ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to athletic scholarships, health and safety, academic success, the collegiate athletic model, amateurism, and higher education H.R. 1804 - Student Athlete Equity Act
Restoring Investment in Improvements Act
Client: RED ROCK RESORTS, INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Depreciation treatment of Qualified Improvement Property, S. 2307 of CARES Act H.R. 1869 - Restoring Investment in Improvements Act S. 803 - Restoring Investment in Improvements Act H.R. 748 CARES Act - Issues related to COVID-19 relief
Coastal and Marine Economies Protection Act
Client: AMERICAN PETROLEUM INSTITUTE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to USMCA, workforce development, and infrastructure; issues relates to offshore exploration; HR 205, HR 1941, HR 1146
Coastal and Marine Economies Protection Act
Client: AMERICAN PETROLEUM INSTITUTE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to workforce development and infrastructure; issues relates to offshore exploration; HR 205, HR 1941, HR 1146
Coastal and Marine Economies Protection Act
Client: AMERICAN PETROLEUM INSTITUTE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to USMCA, workforce development, and infrastructure; issues relates to offshore exploration; HR 205, HR 1941, HR 1146
Protecting and Securing Florida's Coastline Act of 2019
Client: AMERICAN PETROLEUM INSTITUTE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to USMCA, workforce development, and infrastructure; issues relates to offshore exploration; HR 205, HR 1941, HR 1146
Protecting and Securing Florida's Coastline Act of 2019
Client: AMERICAN PETROLEUM INSTITUTE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to USMCA, workforce development, and infrastructure; issues relates to offshore exploration; HR 205, HR 1941, HR 1146
Protecting and Securing Florida's Coastline Act of 2019
Client: AMERICAN PETROLEUM INSTITUTE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to workforce development and infrastructure; issues relates to offshore exploration; HR 205, HR 1941, HR 1146
Issues related to minting and coinage Issues related to payment, H.R. 2650 (Payment Choice Act)
Issues related to minting and coinage Issues related to payment, H.R. 2650 (Payment Choice Act)
Issues related to minting and coinage Issues related to payment, H.R. 2650 (Payment Choice Act), H.R. 7995(Coin Metal Modification Authorization and Cost Savings Act of 2020)
To amend title XVIII of the Social Security Act to improve access to, and utilization of, bone mass measurement benefits under part B of the Medicare program by establishing a minimum payment amount under such part for bone mass measurement.
Client: AMGEN USA INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Medicare Part D; Medicare Part B; S. 1416 - Affordable Prescriptions for Patients Act of 2019; H.R.3 - Lower Drug Costs Now Act of 2019; H.R. 2693 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2019; Issues related to patient access
To amend title XVIII of the Social Security Act to improve access to, and utilization of, bone mass measurement benefits under part B of the Medicare program by establishing a minimum payment amount under such part for bone mass measurement.
Client: AMGEN USA INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Medicare Part D; Medicare Part B; S. 1416 - Affordable Prescriptions for Patients Act of 2019; H.R.3 - Lower Drug Costs Now Act of 2019; H.R. 2693 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2019; Issues related to patient access
To amend title XVIII of the Social Security Act to improve access to, and utilization of, bone mass measurement benefits under part B of the Medicare program by establishing a minimum payment amount under such part for bone mass measurement.
Client: AMGEN USA INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Medicare Part D; Medicare Part B; S. 1416 - Affordable Prescriptions for Patients Act of 2019; H.R.3 - Lower Drug Costs Now Act of 2019; H.R. 2693 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2019; Issues related to patient access
To amend title XVIII of the Social Security Act to improve access to, and utilization of, bone mass measurement benefits under part B of the Medicare program by establishing a minimum payment amount under such part for bone mass measurement.
Client: AMGEN USA INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Medicare Part D; Medicare Part B; S. 1416 - Affordable Prescriptions for Patients Act of 2019; H.R.3 - Lower Drug Costs Now Act of 2019; H.R. 2693 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2019; Issues related to patient access
Patient Access to ESRD New Innovative Devices Act
Client: BAXTER HEALTHCARE CORPORATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Funding issues for Medicare Part B 340 B drug discount program Dialysis reimbursement H.R.2710 - Patient Access to ESRD New Innovative Devices Act
Patient Access to ESRD New Innovative Devices Act
Client: BAXTER HEALTHCARE CORPORATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Funding issues for Medicare Part B 340 B drug discount program Dialysis reimbursement H.R.2710 - Patient Access to ESRD New Innovative Devices Act
Patient Access to ESRD New Innovative Devices Act
Client: BAXTER HEALTHCARE CORPORATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Funding issues for Medicare Part B 340 B drug discount program Dialysis reimbursement H.R.2710 - Patient Access to ESRD New Innovative Devices Act
Patient Access to ESRD New Innovative Devices Act
Client: BAXTER HEALTHCARE CORPORATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Funding issues for Medicare Part B 340 B drug discount program Dialysis reimbursement H.R.2710 - Patient Access to ESRD New Innovative Devices Act
Elijah E. Cummings Lower Drug Costs Now Act
Client: AMGEN USA INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Medicare Part D; Medicare Part B; S. 1416 - Affordable Prescriptions for Patients Act of 2019; H.R.3 - Lower Drug Costs Now Act of 2019; H.R. 2693 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2019; Issues related to patient access
Elijah E. Cummings Lower Drug Costs Now Act
Client: AMGEN USA INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Medicare Part D; Medicare Part B; S. 1416 - Affordable Prescriptions for Patients Act of 2019; H.R.3 - Lower Drug Costs Now Act of 2019; H.R. 2693 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2019; Issues related to patient access
Elijah E. Cummings Lower Drug Costs Now Act
Client: AMGEN USA INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Medicare Part D; Medicare Part B; S. 1416 - Affordable Prescriptions for Patients Act of 2019; H.R.3 - Lower Drug Costs Now Act of 2019; H.R. 2693 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2019; Issues related to patient access
Elijah E. Cummings Lower Drug Costs Now Act
Client: AMGEN USA INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Medicare Part D; Medicare Part B; S. 1416 - Affordable Prescriptions for Patients Act of 2019; H.R.3 - Lower Drug Costs Now Act of 2019; H.R. 2693 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2019; Issues related to patient access
RECOVER Act
Client: PLASTICS INDUSTRY ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues regarding recycling policy and climate change/environmental policy H.R. 5115 - RECOVER Act
RECOVER Act
Client: PLASTICS INDUSTRY ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues regarding recycling policy and climate change/environmental policy H.R. 5115 - RECOVER Act
RECOVER Act
Client: PLASTICS INDUSTRY ASSOCIATION · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues regarding recycling policy and climate change/environmental policy H.R. 5115 - RECOVER Act
Uterine Fibroid Research and Education Act of 2020
Client: ABBVIE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to patient access Issues related to pharmaceutical manufacturing Issues related to treatment of endometriosis Patent reform - S. 1416 - Affordable Prescriptions for Patients Act of 2019 Medicare Part D H.R. 748 CARES Act - Issues related to COVID-19 relief S. 4397/H.R.6383 - Uterine Fibroid Research and Education Act of 2020 H.R.133 - Consolidated Appropriations Act, 2021
Uterine Fibroid Research and Education Act of 2020
Client: ABBVIE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to patient access Issues related to pharmaceutical manufacturing Issues related to treatment of endometriosis Patent reform - S. 1416 - Affordable Prescriptions for Patients Act of 2019 Medicare Part D H.R. 748 CARES Act - Issues related to COVID-19 relief S. 4397/H.R.6383 - Uterine Fibroid Research and Education Act of 2020 H.R.133 - Consolidated Appropriations Act, 2021
Uterine Fibroid Research and Education Act of 2020
Client: ABBVIE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to patient access Issues related to pharmaceutical manufacturing Issues related to treatment of endometriosis Patent reform - S. 1416 - Affordable Prescriptions for Patients Act of 2019 Medicare Part D H.R. 748 CARES Act - Issues related to COVID-19 relief S. 4397/H.R.6383 - Uterine Fibroid Research and Education Act of 2020
ACA stabilization; Medicare Advantage; Medicaid HR 748 CARES Act, HR 6800 HEROES Act - Issues related to COVID-19 relief Tricare telehealth issues Independence at home
CARES Act
Client: THE EARLY CARE AND EDUCATION CONSORTIUM · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to early childhood education; Child Care and Development Block Grant (CCDBG); Child and Adult Care Food Program (CACFP) S.749/H.R.1696 - PACE Act H.R. 748 CARES Act, Issues related to COVID-19 relief
CARES Act
Client: JOHNSON & JOHNSON SERVICES, INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to patient access S. 1416 - Affordable Prescriptions for Patients Act of 2019 HR 748 CARES Act, Issues related to COVID-19 treatment
CARES Act
Client: JOHNSON & JOHNSON SERVICES, INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to patient access S. 1416 - Affordable Prescriptions for Patients Act of 2019 HR 748 CARES Act, Issues related to COVID-19 treatment
ACA stabilization; Medicare Advantage; Medicaid HR 748 CARES Act, HR 6800 HEROES Act - Issues related to COVID-19 relief Tricare telehealth issues Independence at home
Issues related to cell and gene therapy Pharmaceutical pricing Issues related to the development of therapies for rare diseases H.R. 748 CARES Act, Issues related to COVID-19 treatment
Issues related to cell and gene therapy Pharmaceutical pricing Issues related to the development of therapies for rare diseases H.R. 748 CARES Act, Issues related to COVID-19 treatment
Issues related to patient access Issues related to pharmaceutical manufacturing Issues related to treatment of endometriosis Patent reform - S. 1416 - Affordable Prescriptions for Patients Act of 2019 Medicare Part D H.R. 748 CARES Act - Issues related to COVID-19 relief S. 4397/H.R.6383 - Uterine Fibroid Research and Education Act of 2020 H.R.133 - Consolidated Appropriations Act, 2021
Issues related to patient access Issues related to pharmaceutical manufacturing Issues related to treatment of endometriosis Patent reform - S. 1416 - Affordable Prescriptions for Patients Act of 2019 Medicare Part D H.R. 748 CARES Act - Issues related to COVID-19 relief
H.R. 748 CARES Act - Issues related to COVID-19 relief
CARES Act
Client: JOHNSON & JOHNSON SERVICES, INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to patient access S. 1416 - Affordable Prescriptions for Patients Act of 2019 HR 748 CARES Act, Issues related to COVID-19 treatment
CARES Act
Client: THE EARLY CARE AND EDUCATION CONSORTIUM · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to early childhood education; Child Care and Development Block Grant (CCDBG); Child and Adult Care Food Program (CACFP) S.749/H.R.1696 - PACE Act H.R. 748 CARES Act, H.R.133 Consolidated Appropriations Act, 2021 - Issues related to COVID-19 relief
Issues related to patient access Issues related to pharmaceutical manufacturing Issues related to treatment of endometriosis Patent reform - S. 1416 - Affordable Prescriptions for Patients Act of 2019 Medicare Part D H.R. 748 CARES Act - Issues related to COVID-19 relief S. 4397/H.R.6383 - Uterine Fibroid Research and Education Act of 2020
CARES Act
Client: JOHNSON & JOHNSON SERVICES, INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to patient access S. 1416 - Affordable Prescriptions for Patients Act of 2019 HR 748 CARES Act, Issues related to COVID-19 treatment
Issues related to cell and gene therapy Pharmaceutical pricing Issues related to the development of therapies for rare diseases H.R. 748 CARES Act, Issues related to COVID-19 treatment
Issues related to the Supplemental Nutrition Assistance Program S.2220 - issues related to exemptions to the Freedom of Information Act Issues related meat inspection procedures HR 748 CARES Act
CARES Act
Client: JOHNSON & JOHNSON SERVICES, INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to patient access Issues related to patents S. 1416 - Affordable Prescriptions for Patients Act of 2019 HR 748 CARES Act, Issues related to COVID-19 treatment
DIR Reform Rebate Rule Drug Pricing H.R. 748 CARES Act - Issues related to COVID-19 relief
DIR Reform Rebate Rule Drug Pricing H.R. 748 CARES Act - Issues related to COVID-19 relief
Issues related to patient access Issues related to pharmaceutical manufacturing Issues related to treatment of endometriosis Patent reform - S. 1416 - Affordable Prescriptions for Patients Act of 2019 Medicare Part D H.R. 748 CARES Act - Issues related to COVID-19 relief
Pharmacist provider status Drug pricing Pharmacy benefits on military bases H.R. 748 CARES Act - Issues related to COVID-19 relief
Depreciation treatment of Qualified Improvement Property, S. 2307 of CARES Act H.R. 1869 - Restoring Investment in Improvements Act S. 803 - Restoring Investment in Improvements Act H.R. 748 CARES Act - Issues related to COVID-19 relief
HR 748 CARES Act - Issues related to COVID-19 relief Issues related to built in gains tax
ACA stabilization; Medicare Advantage; Medicaid HR 748 CARES Act - Issues related to COVID-19 relief Tricare telehealth issues
ACA stabilization; Medicare Advantage; Medicaid HR 748 CARES Act - Issues related to COVID-19 relief
Issues related to patient access Issues related to pharmaceutical manufacturing Issues related to treatment of endometriosis Patent reform - S. 1416 - Affordable Prescriptions for Patients Act of 2019 Medicare Part D H.R. 748 CARES Act - Issues related to COVID-19 relief S. 4397/H.R.6383 - Uterine Fibroid Research and Education Act of 2020 H.R.133 - Consolidated Appropriations Act, 2021
CARES Act
Client: DEL MONTE FRESH PRODUCE COMPANY · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
HR 748 CARES Act - issues related to COVID-19 relief
Pharmacist provider status Drug pricing Pharmacy benefits on military bases H.R. 748 CARES Act - Issues related to COVID-19 relief
CARES Act
Client: THE EARLY CARE AND EDUCATION CONSORTIUM · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to early childhood education; Child Care and Development Block Grant (CCDBG); Child and Adult Care Food Program (CACFP) S.749/H.R.1696 - PACE Act H.R. 748 CARES Act, Issues related to COVID-19 relief
Coin Metal Modification Authorization and Cost Savings Act of 2020
Client: COINSTAR · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to minting and coinage Issues related to payment, H.R. 2650 (Payment Choice Act), H.R. 7995(Coin Metal Modification Authorization and Cost Savings Act of 2020)
Affordable Prescriptions for Patients Act of 2019
Client: JOHNSON & JOHNSON SERVICES, INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to patient access S. 1416 - Affordable Prescriptions for Patients Act of 2019 HR 748 CARES Act, Issues related to COVID-19 treatment
Affordable Prescriptions for Patients Act of 2019
Client: JOHNSON & JOHNSON SERVICES, INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to patient access Issues related to patents S. 1416 - Affordable Prescriptions for Patients Act of 2019 HR 748 CARES Act, Issues related to COVID-19 treatment
Affordable Prescriptions for Patients Act of 2019
Client: AMGEN USA INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Medicare Part D; Medicare Part B; S. 1416 - Affordable Prescriptions for Patients Act of 2019; H.R.3 - Lower Drug Costs Now Act of 2019; H.R. 2693 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2019; Issues related to patient access
Affordable Prescriptions for Patients Act of 2019
Client: ABBVIE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to patient access Issues related to pharmaceutical manufacturing Issues related to treatment of endometriosis Patent reform - S. 1416 - Affordable Prescriptions for Patients Act of 2019 Medicare Part D H.R. 748 CARES Act - Issues related to COVID-19 relief S. 4397/H.R.6383 - Uterine Fibroid Research and Education Act of 2020 H.R.133 - Consolidated Appropriations Act, 2021
Affordable Prescriptions for Patients Act of 2019
Client: JOHNSON & JOHNSON SERVICES, INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to patient access S. 1416 - Affordable Prescriptions for Patients Act of 2019 HR 748 CARES Act, Issues related to COVID-19 treatment
Affordable Prescriptions for Patients Act of 2019
Client: JOHNSON & JOHNSON SERVICES, INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to patient access S. 1416 - Affordable Prescriptions for Patients Act of 2019 HR 748 CARES Act, Issues related to COVID-19 treatment
Affordable Prescriptions for Patients Act of 2019
Client: ABBVIE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to patient access Issues related to pharmaceutical manufacturing Issues related to treatment of endometriosis Patent reform - S. 1416 - Affordable Prescriptions for Patients Act of 2019 Medicare Part D H.R. 748 CARES Act - Issues related to COVID-19 relief S. 4397/H.R.6383 - Uterine Fibroid Research and Education Act of 2020
Affordable Prescriptions for Patients Act of 2019
Client: ABBVIE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to patient access Issues related to pharmaceutical manufacturing Issues related to treatment of endometriosis Patent reform - S. 1416 - Affordable Prescriptions for Patients Act of 2019 Medicare Part D H.R. 748 CARES Act - Issues related to COVID-19 relief
Affordable Prescriptions for Patients Act of 2019
Client: AMGEN USA INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Medicare Part D; Medicare Part B; S. 1416 - Affordable Prescriptions for Patients Act of 2019; H.R.3 - Lower Drug Costs Now Act of 2019; H.R. 2693 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2019; Issues related to patient access
Affordable Prescriptions for Patients Act of 2019
Client: JOHNSON & JOHNSON SERVICES, INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to patient access S. 1416 - Affordable Prescriptions for Patients Act of 2019 HR 748 CARES Act, Issues related to COVID-19 treatment
Affordable Prescriptions for Patients Act of 2019
Client: ABBVIE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to patient access Issues related to pharmaceutical manufacturing Issues related to treatment of endometriosis Patent reform - S. 1416 - Affordable Prescriptions for Patients Act of 2019 Medicare Part D H.R. 748 CARES Act - Issues related to COVID-19 relief
Affordable Prescriptions for Patients Act of 2019
Client: ABBVIE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to patient access Issues related to pharmaceutical manufacturing Issues related to treatment of endometriosis Patent reform - S. 1416 - Affordable Prescriptions for Patients Act of 2019 Medicare Part D H.R. 748 CARES Act - Issues related to COVID-19 relief S. 4397/H.R.6383 - Uterine Fibroid Research and Education Act of 2020 H.R.133 - Consolidated Appropriations Act, 2021
Affordable Prescriptions for Patients Act of 2019
Client: AMGEN USA INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Medicare Part D; Medicare Part B; S. 1416 - Affordable Prescriptions for Patients Act of 2019; H.R.3 - Lower Drug Costs Now Act of 2019; H.R. 2693 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2019; Issues related to patient access
Affordable Prescriptions for Patients Act of 2019
Client: AMGEN USA INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Medicare Part D; Medicare Part B; S. 1416 - Affordable Prescriptions for Patients Act of 2019; H.R.3 - Lower Drug Costs Now Act of 2019; H.R. 2693 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2019; Issues related to patient access
Open and Responsive Government Act of 2019
Client: HEB GROCERY COMPANY, LP · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to the Supplemental Nutrition Assistance Program S.2220 - issues related to exemptions to the Freedom of Information Act Issues related meat inspection procedures Issues related to COVID-19
Open and Responsive Government Act of 2019
Client: HEB GROCERY COMPANY, LP · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to the Supplemental Nutrition Assistance Program S.2220 Open and Responsive Government Act of 2019 - issues related to exemptions to the Freedom of Information Act Issues related meat inspection procedures H.R.133 Consolidated Appropriations Act, 2021 - Issues related to COVID-19
Open and Responsive Government Act of 2019
Client: HEB GROCERY COMPANY, LP · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to the Supplemental Nutrition Assistance Program S.2220 - issues related to exemptions to the Freedom of Information Act Issues related meat inspection procedures Issues related to COVID-19
Open and Responsive Government Act of 2019
Client: HEB GROCERY COMPANY, LP · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to the Supplemental Nutrition Assistance Program S.2220 - issues related to exemptions to the Freedom of Information Act Issues related meat inspection procedures HR 748 CARES Act
World Language Advancement and Readiness Act of 2019
Client: RED ROCK RESORTS, INC. · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Depreciation treatment of Qualified Improvement Property, S. 2307 of CARES Act H.R. 1869 - Restoring Investment in Improvements Act S. 803 - Restoring Investment in Improvements Act H.R. 748 CARES Act - Issues related to COVID-19 relief
Uterine Fibroid Research and Education Act of 2020
Client: ABBVIE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to patient access Issues related to pharmaceutical manufacturing Issues related to treatment of endometriosis Patent reform - S. 1416 - Affordable Prescriptions for Patients Act of 2019 Medicare Part D H.R. 748 CARES Act - Issues related to COVID-19 relief S. 4397/H.R.6383 - Uterine Fibroid Research and Education Act of 2020 H.R.133 - Consolidated Appropriations Act, 2021
Uterine Fibroid Research and Education Act of 2020
Client: ABBVIE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to patient access Issues related to pharmaceutical manufacturing Issues related to treatment of endometriosis Patent reform - S. 1416 - Affordable Prescriptions for Patients Act of 2019 Medicare Part D H.R. 748 CARES Act - Issues related to COVID-19 relief S. 4397/H.R.6383 - Uterine Fibroid Research and Education Act of 2020 H.R.133 - Consolidated Appropriations Act, 2021
Uterine Fibroid Research and Education Act of 2020
Client: ABBVIE · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to patient access Issues related to pharmaceutical manufacturing Issues related to treatment of endometriosis Patent reform - S. 1416 - Affordable Prescriptions for Patients Act of 2019 Medicare Part D H.R. 748 CARES Act - Issues related to COVID-19 relief S. 4397/H.R.6383 - Uterine Fibroid Research and Education Act of 2020
PACE Act
Client: THE EARLY CARE AND EDUCATION CONSORTIUM · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues related to early childhood education; Child Care and Development Block Grant (CCDBG); Child and Adult Care Food Program (CACFP) S.749/H.R.1696 - PACE Act H.R. 748 CARES Act, Issues related to COVID-19 relief
Issues related to workforce access to education
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
MCDONALD'S CORPORATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2021 · first_quarter · 1A
Issues related to workforce access to education
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
ABBVIE via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2021 · first_quarter · 1A
Issues related to patient access, Issues related to pharmaceutical manufacturing, Issues related to treatment of endometriosis, Patent reform H.R.1319 - American Rescue Plan Act of 2021
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
MCDONALD'S CORPORATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2021 · first_quarter · Q1
Issues related to workforce access to education
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
ICONSTITUENT via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2021 · first_quarter · 1T
Issues related to connecting congressional offices with iConstituent's software tools
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBVIE via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2021 · first_quarter · Q1
Issues related to patient access, Issues related to pharmaceutical manufacturing, Issues related to treatment of endometriosis, Patent reform H.R.1319 - American Rescue Plan Act of 2021
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
CENTENE CORPORATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · fourth_quarter · 4A
ACA stabilization; Medicare Advantage; Medicaid H.R.133 - Consolidated Appropriations Act, 2021 - Issues related to COVID-19 relief Tricare telehealth issues Independence at home
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States, SENATE
MCDONALD'S CORPORATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · fourth_quarter · Q4
Issues related to franchisees Issues related to workforce Issues related to the National Labor Relations Act/National Labor Relations Board
Issues related to workforce access to education
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVARTIS via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · fourth_quarter · Q4
Issues related to cell and gene therapy Pharmaceutical pricing Issues related to the development of therapies for rare diseases Issues related to COVID-19
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
CENTENE CORPORATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · fourth_quarter · Q4
ACA stabilization; Medicare Advantage; Medicaid H.R.133 - Consolidated Appropriations Act, 2021 - Issues related to COVID-19 relief Tricare telehealth issues Independence at home
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States, SENATE
BAXTER HEALTHCARE CORPORATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · fourth_quarter · Q4
Funding issues for Medicare Part B 340 B drug discount program Dialysis reimbursement H.R.2710 - Patient Access to ESRD New Innovative Devices Act
Telemedicine Availability of medical products Issues related to malnutrition
Filing targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, SENATE
ABBVIE via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · fourth_quarter · 4A
Issues related to patient access Issues related to pharmaceutical manufacturing Issues related to treatment of endometriosis Patent reform - S. 1416 - Affordable Prescriptions for Patients Act of 2019 Medicare Part D H.R. 748 CARES Act - Issues related to COVID-19 relief S. 4397/H.R.6383 - Uterine Fibroid Research and Education Act of 2020 H.R.133 - Consolidated Appropriations Act, 2021
Filing targets: Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Natl Economic Council (NEC), SENATE, U.S. Trade Representative (USTR)
ABBVIE via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · fourth_quarter · Q4
Issues related to patient access Issues related to pharmaceutical manufacturing Issues related to treatment of endometriosis Patent reform - S. 1416 - Affordable Prescriptions for Patients Act of 2019 Medicare Part D H.R. 748 CARES Act - Issues related to COVID-19 relief S. 4397/H.R.6383 - Uterine Fibroid Research and Education Act of 2020 H.R.133 - Consolidated Appropriations Act, 2021
Filing targets: Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Natl Economic Council (NEC), SENATE, U.S. Trade Representative (USTR)
PURDUE PHARMA L.P. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · fourth_quarter · Q4
Monitoring legislative and regulatory activities impacting the pharmaceutical industry
WALGREEN CO. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · fourth_quarter · Q4
DIR Reform Rebate Rule Drug Pricing Issues related to COVID-19 relief
Pharmacist provider status Drug pricing Pharmacy benefits on military bases Issues related to COVID-19 relief
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Office of the Vice President of the United States, SENATE, State, Dept of (DOS)
THE EARLY CARE AND EDUCATION CONSORTIUM via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · fourth_quarter · Q4
Issues related to early childhood education; Child Care and Development Block Grant (CCDBG); Child and Adult Care Food Program (CACFP) S.749/H.R.1696 - PACE Act H.R. 748 CARES Act, H.R.133 Consolidated Appropriations Act, 2021 - Issues related to COVID-19 relief
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
SPARK THERAPEUTICS, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · fourth_quarter · Q4
Issues related to the development of therapies for rare diseases Patient Affordability Value and Efficiency Act
ROYAL CARIBBEAN CRUISES LTD. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · fourth_quarter · Q4
Issues related to the cruise industry
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RED ROCK RESORTS, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · fourth_quarter · Q4
Issues related to COVID-19 relief
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PWC US GROUP LLP via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · fourth_quarter · Q4
Issues related to financial services, taxes, and trade Legislation related to PCAOB Issues related to privacy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PLASTICS INDUSTRY ASSOCIATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · fourth_quarter · Q4
Issues regarding recycling policy and climate change/environmental policy H.R. 5115 - RECOVER Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PATHEMAGX via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · fourth_quarter · Q4
Issues related to genomic testing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL HEAD START ASSOCIATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · fourth_quarter · Q4
Issues related to funding for Head Start and Early Head Start programs Labor and Health and Human Services appropriations for FY21 Issues related to the impacts of the opioids crisis
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
NATIONAL COLLEGIATE ATHLETIC ASSOCIATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · fourth_quarter · Q4
Issues related to athletic scholarships, health and safety, academic success, the collegiate athletic model, amateurism, and higher education H.R. 1804 - Student Athlete Equity Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JOHNSON & JOHNSON SERVICES, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · fourth_quarter · Q4
Issues related to patient access Issues related to patents S. 1416 - Affordable Prescriptions for Patients Act of 2019 HR 748 CARES Act, Issues related to COVID-19 treatment
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ICONSTITUENT via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · fourth_quarter · Q4
Issues related to connecting congressional offices with iConstituent's software tools
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEB GROCERY COMPANY, LP via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · fourth_quarter · Q4
Issues related to trade treaties and proposed USMCA; Issues related to food importation
Issues related to the Supplemental Nutrition Assistance Program S.2220 Open and Responsive Government Act of 2019 - issues related to exemptions to the Freedom of Information Act Issues related meat inspection procedures H.R.133 Consolidated Appropriations Act, 2021 - Issues related to COVID-19
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRIENDS OF THE NATIONAL MUSEUM OF AMERICAN JEWISH HISTORY, LLC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · fourth_quarter · Q4
Issues related to appropriations regarding funding for museums
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States, SENATE, Smithsonian Institution
FEDEX CORPORATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · fourth_quarter · Q4
Trucking efficiency issue Issues related to cargo aviation
Filing targets: HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), Office of Management & Budget (OMB), SENATE
CONSTELLATION ENERGY GENERATION, LLC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · fourth_quarter · Q4
Issues related to energy taxes; general corporate tax issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DEL MONTE FRESH PRODUCE COMPANY via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · fourth_quarter · Q4
Transfer pricing issues
International relations issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), Treasury, Dept of, White House Office
COINSTAR via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · fourth_quarter · Q4
Issues related to minting and coinage Issues related to payment, H.R. 2650 (Payment Choice Act), H.R. 7995(Coin Metal Modification Authorization and Cost Savings Act of 2020)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CENGAGE via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · fourth_quarter · Q4
Issues related to higher education and workforce development Issues related to COVID-19
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CARS.COM via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · fourth_quarter · Q4
Issues related to essential employee designation Issues related to COVID-19 in the automotive sector
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CADENCE EDUCATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · fourth_quarter · Q4
Issues related to early childhood education
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BECKMAN COULTER DIAGNOSTICS via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · fourth_quarter · Q4
Issues related to COVID-19; H.R. 133 Consolidated Appropriations Act, 2021
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States, SENATE
AMP ROBOTICS via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · fourth_quarter · Q4
Issues related to recycling technology
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
AMGEN USA INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · fourth_quarter · 4T
Medicare Part D; Medicare Part B; S. 1416 - Affordable Prescriptions for Patients Act of 2019; H.R.3 - Lower Drug Costs Now Act of 2019; H.R. 2693 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2019; Issues related to patient access
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN PETROLEUM INSTITUTE via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · fourth_quarter · Q4
Issues related to workforce development and infrastructure; issues relates to offshore exploration
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ICONSTITUENT via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · fourth_quarter · RR
Issues related to connecting congressional offices with iConstituent's legislative software tools
PATHEMAGX via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · third_quarter · Q3
Issues related to genomic testing
CADENCE EDUCATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · third_quarter · Q3
Issues related to early childhood education
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
BECKMAN COULTER DIAGNOSTICS via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · third_quarter · Q3
Issues related to COVID-19
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
PURDUE PHARMA L.P. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · third_quarter · Q3
Monitoring legislative and regulatory activities impacting the pharmaceutical industry
WALGREEN CO. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · third_quarter · Q3
DIR Reform Rebate Rule Drug Pricing Issues related to COVID-19 relief
Pharmacist provider status Drug pricing Pharmacy benefits on military bases Issues related to COVID-19 relief
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), White House Office
THE EARLY CARE AND EDUCATION CONSORTIUM via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · third_quarter · Q3
Issues related to early childhood education; Child Care and Development Block Grant (CCDBG); Child and Adult Care Food Program (CACFP) S.749/H.R.1696 - PACE Act H.R. 748 CARES Act, Issues related to COVID-19 relief
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, White House Office
SPARK THERAPEUTICS, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · third_quarter · Q3
Issues related to the development of therapies for rare diseases Patient Affordability Value and Efficiency Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROYAL CARIBBEAN CRUISES LTD. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · third_quarter · Q3
Issues related to the cruise industry, including the coronavirus pandemic
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RED ROCK RESORTS, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · third_quarter · Q3
Issues related to COVID-19 relief
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
PWC US GROUP LLP via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · third_quarter · Q3
Issues related to financial services, taxes, and trade Legislation related to PCAOB Issues related to privacy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PLASTICS INDUSTRY ASSOCIATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · third_quarter · Q3
Issues regarding recycling policy and climate change/environmental policy H.R. 5115 - RECOVER Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVARTIS via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · third_quarter · Q3
Issues related to cell and gene therapy Pharmaceutical pricing Issues related to the development of therapies for rare diseases Issues related to COVID-19
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States
NATIONAL HEAD START ASSOCIATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · third_quarter · Q3
Issues related to funding for Head Start and Early Head Start programs Labor and Health and Human Services appropriations for FY20 Issues related to the impacts of the opioids crisis
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
NATIONAL COLLEGIATE ATHLETIC ASSOCIATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · third_quarter · Q3
Issues related to athletic scholarships, health and safety, academic success, the collegiate athletic model, amateurism, and higher education H.R. 1804 - Student Athlete Equity Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MCDONALD'S CORPORATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · third_quarter · Q3
Issues related to workforce access education
Issues related to franchisees Issues related to workforce Issues related to the National Labor Relations Act/National Labor Relations Board
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JOHNSON & JOHNSON SERVICES, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · third_quarter · Q3
Issues related to patient access S. 1416 - Affordable Prescriptions for Patients Act of 2019 HR 748 CARES Act, Issues related to COVID-19 treatment
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEB GROCERY COMPANY, LP via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · third_quarter · Q3
Issues related to the Supplemental Nutrition Assistance Program S.2220 - issues related to exemptions to the Freedom of Information Act Issues related meat inspection procedures Issues related to COVID-19
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRIENDS OF THE NATIONAL MUSEUM OF AMERICAN JEWISH HISTORY, LLC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · third_quarter · 3A
Issues related to appropriations regarding funding for museums
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, Smithsonian Institution, White House Office
FRIENDS OF THE NATIONAL MUSEUM OF AMERICAN JEWISH HISTORY, LLC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · third_quarter · Q3
Issues related to appropriations regarding funding for museums
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, White House Office
FEDEX CORPORATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · third_quarter · Q3
Trucking efficiency issue Issues related to cargo aviation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
CONSTELLATION ENERGY GENERATION, LLC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · third_quarter · Q3
Implementation of H.R. 1 (Tax Cuts and Jobs Act of 2017); energy taxes
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DEL MONTE FRESH PRODUCE COMPANY via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · third_quarter · Q3
International relations issues
Issues related to COVID-19 relief
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), Treasury, Dept of
COINSTAR via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · third_quarter · Q3
Issues related to minting and coinage Issues related to payment, H.R. 2650 (Payment Choice Act)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CENTENE CORPORATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · third_quarter · Q3
ACA stabilization; Medicare Advantage; Medicaid HR 748 CARES Act, HR 6800 HEROES Act - Issues related to COVID-19 relief Tricare telehealth issues Independence at home
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
CENGAGE via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · third_quarter · Q3
Issues related to higher education and workforce development Issues related to COVID-19
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, White House Office
CARS.COM via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · third_quarter · Q3
Issues related to essential employee designation Issues related to COVID-19 in the automotive sector
Filing targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
BAXTER HEALTHCARE CORPORATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · third_quarter · Q3
Telemedicine Availability of medical products Issues related to malnutrition
Funding issues for Medicare Part B 340 B drug discount program Dialysis reimbursement H.R.2710 - Patient Access to ESRD New Innovative Devices Act
Filing targets: HOUSE OF REPRESENTATIVES
AMP ROBOTICS via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · third_quarter · Q3
Issues related to recycling technology
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
AMGEN USA INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · third_quarter · Q3
Medicare Part D; Medicare Part B; S. 1416 - Affordable Prescriptions for Patients Act of 2019; H.R.3 - Lower Drug Costs Now Act of 2019; H.R. 2693 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2019; Issues related to patient access
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN PETROLEUM INSTITUTE via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · third_quarter · Q3
Issues related to workforce development and infrastructure; issues relates to offshore exploration; HR 205, HR 1941, HR 1146
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBVIE via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · third_quarter · Q3
Issues related to patient access Issues related to pharmaceutical manufacturing Issues related to treatment of endometriosis Patent reform - S. 1416 - Affordable Prescriptions for Patients Act of 2019 Medicare Part D H.R. 748 CARES Act - Issues related to COVID-19 relief S. 4397/H.R.6383 - Uterine Fibroid Research and Education Act of 2020
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
PATHEMAGX via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · third_quarter · RR
Issues related to genetic and pathogenic testing
ROYAL CARIBBEAN CRUISES LTD. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · second_quarter · 2A
Issues related to the cruise industry, including the coronavirus pandemic
Filing targets: SENATE
ROYAL CARIBBEAN CRUISES LTD. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · second_quarter · 2A
Issues related to Coronavirus pandemic
Filing targets: SENATE
FEDEX CORPORATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · second_quarter · Q2
Trucking efficiency issue Issues related to cargo aviation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA L.P. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · second_quarter · Q2
Monitoring legislative and regulatory activities impacting the pharmaceutical industry
WALGREEN CO. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · second_quarter · Q2
DIR Reform Rebate Rule Drug Pricing H.R. 748 CARES Act - Issues related to COVID-19 relief
Pharmacist provider status Drug pricing Pharmacy benefits on military bases H.R. 748 CARES Act - Issues related to COVID-19 relief
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Economic Council (NEC), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA), White House Office
THE EARLY CARE AND EDUCATION CONSORTIUM via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · second_quarter · Q2
Issues related to early childhood education; Child Care and Development Block Grant (CCDBG); Child and Adult Care Food Program (CACFP) S.749/H.R.1696 - PACE Act H.R. 748 CARES Act, Issues related to COVID-19 relief
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
SPARK THERAPEUTICS, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · second_quarter · Q2
Issues related to the development of therapies for rare diseases Patient Affordability Value and Efficiency Act
ROYAL CARIBBEAN CRUISES LTD. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · second_quarter · Q2
Issues related to COVID-19, CARES Act
Filing targets: SENATE
RED ROCK RESORTS, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · second_quarter · Q2
H.R. 748 CARES Act - Issues related to COVID-19 relief
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
PWC US GROUP LLP via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · second_quarter · Q2
Issues related to financial services, taxes, and trade Legislation related to PCAOB
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PLASTICS INDUSTRY ASSOCIATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · second_quarter · Q2
Issues regarding recycling policy and climate change/environmental policy H.R. 5115 - RECOVER Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARK HOTELS & RESORTS, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · second_quarter · Q2
HR 748 CARES Act - Issues related to COVID-19 relief Issues related to built in gains tax
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVARTIS via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · second_quarter · Q2
Issues related to cell and gene therapy Pharmaceutical pricing Issues related to the development of therapies for rare diseases H.R. 748 CARES Act, Issues related to COVID-19 treatment
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), Office of the Vice President of the United States, SENATE
NATIONAL CABLE & TELECOMMUNICATIONS ASSOCIATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · second_quarter · Q2
Broadband Net neutrality/Title II Spectrum ISP privacy Tax reform Infrastructure Universal service
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL HEAD START ASSOCIATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · second_quarter · Q2
Issues related to funding for Head Start and Early Head Start programs Labor and Health and Human Services appropriations for FY20 Issues related to the impacts of the opioids crisis
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
MCDONALD'S CORPORATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · second_quarter · Q2
Issues related to workforce access education
Issues related to food and nutrition policies and standards
Issues related to sustainability
JOHNSON & JOHNSON SERVICES, INC. via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · second_quarter · Q2
Issues related to patient access S. 1416 - Affordable Prescriptions for Patients Act of 2019 HR 748 CARES Act, Issues related to COVID-19 treatment
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEB GROCERY COMPANY, LP via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · second_quarter · Q2
Issues related to the Supplemental Nutrition Assistance Program S.2220 - issues related to exemptions to the Freedom of Information Act Issues related meat inspection procedures Issues related to COVID-19
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSTELLATION ENERGY GENERATION, LLC via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · second_quarter · Q2
Implementation of H.R. 1 (Tax Cuts and Jobs Act of 2017); energy taxes
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
DEL MONTE FRESH PRODUCE COMPANY via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · second_quarter · Q2
International relations issues
Issues related to COVID-19 relief
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
COINSTAR via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · second_quarter · Q2
Issues related to minting and coinage Issues related to payment, H.R. 2650 (Payment Choice Act)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CENTENE CORPORATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · second_quarter · Q2
ACA stabilization; Medicare Advantage; Medicaid HR 748 CARES Act - Issues related to COVID-19 relief Tricare telehealth issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CENGAGE via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · second_quarter · Q2
Issues related to higher education and workforce development Issues related to COVID-19
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, White House Office
CARS.COM via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · second_quarter · Q2
Issues related to essential employee designation Issues related to COVID-19 in the automotive sector
Filing targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
CADENCE EDUCATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · second_quarter · Q2
Issues related to early childhood education
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
BECKMAN COULTER DIAGNOSTICS via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · second_quarter · Q2
Issues related to COVID-19
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAXTER HEALTHCARE CORPORATION via BROWNSTEIN HYATT FARBER SCHRECK, LLP
2020 · second_quarter · Q2
Telemedicine Availability of medical products
Funding issues for Medicare Part B 340 B drug discount program Dialysis reimbursement H.R.2710 - Patient Access to ESRD New Innovative Devices Act
Filing targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Treasury, Dept of
Issues related to franchisees Issues related to workforce Issues related to the National Labor Relations Act/National Labor Relations Board
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE